Early Study Finds MGC018 Active in Resistant Skin Cancer

Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…

Read More

Pancreatic Cancer Prevention and Warning Signs

Jennifer L. Gnerlich, MD, FACS, FSSO is a specialty care physician in general surgery and complex general surgical oncology at Inova Schar Cancer Institute. She specializes in upper Gastrointestinal (GI) cancers and carcinomatosis. With the recent deaths of Ruth Bader Ginsburg and Alex Trebek, more people want to know about pancreatic cancer. While not a…

Read More

Colorectal Cancer Screening Should Begin at Age 45

Arthur Winer, MD, is a specialty care physician at Inova Schar Cancer Institute. Dr. Winer is board-certified in internal medicine, hematology and medical oncology. He is a practicing gastrointestinal medical oncologist and has clinical interests in colorectal, esophageal, gastrointestinal, liver and pancreatic cancers. For decades, experts advised people to begin colorectal cancer screening at age…

Read More

Is Radiation Necessary After Breast Cancer Surgery?

doctor comforting a patient

Ductal carcinoma in situ (DCIS) is a cancer that forms in the cells that line the milk ducts, and it accounts for 20% of new breast cancer diagnoses. The most common treatment is breast-conserving surgery to remove the cancerous tissue. While only a small percentage of women experience an invasive cancer event following surgery, radiation…

Read More

Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study

person using a stylus on a tablet

The COVID-19 pandemic has spurred cancer teams to find new ways to care safely for patients with cancer, in particular outpatients who have tested positive for COVID-19 but do not require hospitalization. Inova Schar Cancer Institute’s physicians and advanced practice providers utilized a program called remote patient monitoring (RPM) to observe COVID-positive outpatients. To study…

Read More

Laura Matthews, MBA, MPH Named as Vice President and Administrator of Inova Schar Cancer Institute

inova logo

Inova Schar Cancer Institute is proud to announce that Laura Matthews, MBA, MPH, has been named as Inova Schar’s Vice President and Administrator. Laura joined Inova in 2014 as part of the strategic planning team before joining the Inova Schar team as Director of Operations and Growth in January 2018. She began working as the Acting…

Read More